Pharnext S.C.A Past Earnings Performance

Past criteria checks 0/6

Pharnext S.C.A's earnings have been declining at an average annual rate of -7.9%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 11.3% per year.

Key information

-7.9%

Earnings growth rate

n/a

EPS growth rate

Biotechs Industry Growth30.8%
Revenue growth rate-11.3%
Return on equityn/a
Net Margin-16,004.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Pharnext's (EPA:ALPHA) Stock Price Has Reduced 66% In The Past Three Years

Feb 01
Pharnext's (EPA:ALPHA) Stock Price Has Reduced 66% In The Past Three Years

We Might See A Profit From Pharnext SA (EPA:ALPHA) Soon

Dec 09
We Might See A Profit From Pharnext SA (EPA:ALPHA) Soon

Revenue & Expenses Breakdown

How Pharnext S.C.A makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALPHA Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-2840
30 Sep 234-2550
30 Jun 232-32820
31 Mar 232-35920
31 Dec 227-2870
30 Sep 225-32710
30 Jun 223-36720
31 Mar 223-33720
31 Dec 214-31720
30 Sep 214-28719
30 Jun 214-26818
31 Mar 213-24816
31 Dec 203-22814
30 Sep 203-21813
30 Jun 203-20813
31 Mar 203-22814
31 Dec 194-23815
30 Sep 194-24816
30 Jun 194-25817
31 Mar 195-23817
31 Dec 187-21718
30 Sep 187-20717
30 Jun 187-18617
31 Mar 185-19616
31 Dec 173-20616
30 Sep 173-20616
30 Jun 174-20516
31 Mar 174-19515
31 Dec 164-17414
30 Sep 164-16412
30 Jun 163-14410
31 Mar 163-1249
31 Dec 153-1148
31 Dec 143-1147
31 Dec 133-939

Quality Earnings: ALPHA is currently unprofitable.

Growing Profit Margin: ALPHA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALPHA is unprofitable, and losses have increased over the past 5 years at a rate of 7.9% per year.

Accelerating Growth: Unable to compare ALPHA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALPHA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).


Return on Equity

High ROE: ALPHA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies